{
    "id": 27613,
    "fullName": "CTNNBL1 - RAF1",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "CTNNBL1-RAF1 results from the fusion of CTNNBL1 and RAF1, resulting in mTORC1 signaling, altered acinar morphology, and increased cell survival (PMID: 29242214). CTNNBL1-RAF1 fusion has been identified in hormone-receptor positive breast cancer (PMID: 29242214).",
            "references": [
                {
                    "id": 11223,
                    "pubMedId": 29242214,
                    "title": "Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29242214"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 56259,
        "geneSymbol": "CTNNBL1",
        "terms": [
            "CTNNBL1",
            "C20orf33",
            "dJ633O20.1",
            "NAP",
            "P14L",
            "PP8304"
        ]
    },
    "variant": "CTNNBL1 - RAF1",
    "createDate": "04/16/2018",
    "updateDate": "04/16/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 5894,
                "geneSymbol": "RAF1",
                "terms": [
                    "RAF1",
                    "c-Raf",
                    "CMD1NN",
                    "CRAF",
                    "NS5",
                    "Raf-1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 13642,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, estrogen-receptor positive breast cancer cells expressing CTNNBL1-RAF1 were resistant to Mekinist (trametinib) in culture (PMID: 29242214).",
            "molecularProfile": {
                "id": 29163,
                "profileName": "CTNNBL1 - RAF1"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 60075,
                "name": "estrogen-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 11223,
                    "pubMedId": 29242214,
                    "title": "Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29242214"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29163,
            "profileName": "CTNNBL1 - RAF1",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}